These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23433851)

  • 1. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
    Camelo-Santos J; do Prado Barbosa A; de Paula Silveira-Lacerda E; Guillo LA
    Biomed Pharmacother; 2013 Mar; 67(2):103-7. PubMed ID: 23433851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?
    Bedewy AM; El-Maghraby SM
    Hematology; 2013 Jul; 18(4):211-6. PubMed ID: 23394475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes.
    Papadakis ED; Soulitzis N; Spandidos DA
    Br J Cancer; 2002 Oct; 87(9):1013-8. PubMed ID: 12434294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of BCR-ABL transcript levels based on Sokal prognostic score in chronic myeloid leukemia patients treated with imatinib.
    Ashariati A; Ugroseno S
    Acta Med Indones; 2013 Apr; 45(2):107-13. PubMed ID: 23770790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of P53 codon 72 polymorphism and ameloblastoma.
    Kitkumthorn N; Yanatatsaneejit P; Rabalert J; Dhammawipark C; Mutirangura A
    Oral Dis; 2010 Oct; 16(7):631-5. PubMed ID: 20412452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: the association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib.
    Liu YC; Hsiao HH; Yang WC; Liu TC; Chang CS; Yang MY; Lin PM; Hsu JF; Lee CP; Lin SF
    Mol Carcinog; 2014 Dec; 53(12):951-9. PubMed ID: 23818300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients.
    Elghannam DM; Ibrahim L; Ebrahim MA; Azmy E; Hakem H
    Hematology; 2014 Apr; 19(3):123-8. PubMed ID: 23683876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
    Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
    Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.
    Chen RH; Chang CT; Wang TY; Huang WL; Tsai CH; Tsai FJ
    J Clin Lab Anal; 2008; 22(5):321-6. PubMed ID: 18803266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
    Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
    Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population.
    Camargo-Kosugi CM; D'Amora P; Kleine JP; Carvalho CV; Sato H; Schor E; Silva ID
    Genet Mol Res; 2014 Aug; 13(3):6503-11. PubMed ID: 25177931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
    Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
    Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of polymorphisms in codons 11, 72 and 248 of TP53 in Brazilian women with breast cancer.
    Almeida BC; Kleine JP; Camargo-Kosugi CM; Lisboa MR; França CN; França JP; Silva ID
    Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.